Atopic dermatitis: Current standards of diagnosis and treatment, including the latest methods of management

[1] Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016; 387: 1109–1122. WeidingerS NovakN Atopic dermatitis Lancet. 2016 387 1109 1122 10.1016/S0140-6736(15)00149-X26377142 Search in Google Scholar

[2] Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther. 2006; 19: 104–107. ChamlinSL The psychosocial burden of childhood atopic dermatitis Dermatol Ther. 2006 19 104 107 10.1111/j.1529-8019.2006.00060.x16669993 Search in Google Scholar

[3] Boothe WD, Tarbox JA, Tarbox MB. Atopic dermatitis: Pathophysiology. Adv Exp Med Biol. 2017; 1027: 21–37. BootheWD TarboxJA TarboxMB Atopic dermatitis: Pathophysiology Adv Exp Med Biol. 2017 1027 21 37 10.1007/978-3-319-64804-0_329063428 Search in Google Scholar

[4] Lee SI, Kim J, Han Y, Ahn K. A proposal: Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pac Allergy. 2011; 1: 53–63. LeeSI KimJ HanY AhnK A proposal: Atopic Dermatitis Organizer (ADO) guideline for children Asia Pac Allergy. 2011 1 53 63 10.5415/apallergy.2011.1.2.53320625522053298 Search in Google Scholar

[5] Asher MI, Montefort S, Björksten B, Lai CKW, Strachan DP, Weiland SK, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional survays. Lancet. 2006; 368: 733–743. AsherMI MontefortS BjörkstenB LaiCKW StrachanDP WeilandSK WilliamsH Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional survays Lancet. 2006 368 733 743 10.1016/S0140-6736(06)69283-016935684 Search in Google Scholar

[6] Ring J. Atopic dermatitis. Eczema. Springer International Publishing Switzerland, 2016. RingJ Atopic dermatitis. Eczema Springer International Publishing Switzerland 2016 10.1007/978-3-319-22243-1 Search in Google Scholar

[7] De Veiga SP. Epidemiology of atopic dermatitis: A review. Allergy Asthma Proc. 2012; 33: 227–234. De VeigaSP Epidemiology of atopic dermatitis: A review Allergy Asthma Proc. 2012 33 227 234 10.2500/aap.2012.33.356922584191 Search in Google Scholar

[8] Kasperska-Zając A, Koczyn-Baron E. Etiopatogeneza atopowego zapalenia skóry. Pol Merkuriusz Lek. 2011; 31: 309–312. Kasperska-ZającA Koczyn-BaronE Etiopatogeneza atopowego zapalenia skóry Pol Merkuriusz Lek. 2011 31 309 312 Search in Google Scholar

[9] Otsuka A, Nomura T, Rerknimitr P, Seidel JA, Honda T., Kabashima K. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev. 2017; 278: 246. OtsukaA NomuraT RerknimitrP SeidelJA HondaT. KabashimaK The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis Immunol Rev. 2017 278 246 10.1111/imr.1254528658541 Search in Google Scholar

[10] Nutten S. Atopic dermatitis: Global epidemiology and risk factors. Ann Nutr Metabol. 2015; 66: 8–16. NuttenS Atopic dermatitis: Global epidemiology and risk factors Ann Nutr Metabol. 2015 66 8 16 10.1159/00037022025925336 Search in Google Scholar

[11] Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W, Kaczmarski M, Kowalewski C, Kruszewski J, Maj J, et al. Atopowe zapalenie skóry – aktualne wytyczne terapeutyczne. Stanowisko ekspertów Sekcji Dermatologicznej Polskiego Towarzystwa Alergologicznego i Sekcji Alergologicznej Polskiego Towarzystwa Dermatologicznego. Post Dermatol Alergol. 2015; 32: 239–249. NowickiR TrzeciakM WilkowskaA Sokołowska-WojdyłoM Ługowska-UmerH Barańska-RybakW KaczmarskiM KowalewskiC KruszewskiJ MajJ Atopowe zapalenie skóry – aktualne wytyczne terapeutyczne. Stanowisko ekspertów Sekcji Dermatologicznej Polskiego Towarzystwa Alergologicznego i Sekcji Alergologicznej Polskiego Towarzystwa Dermatologicznego Post Dermatol Alergol. 2015 32 239 249 10.1016/j.alergo.2016.02.004 Search in Google Scholar

[12] Thomsen SF, Ulrik CS, Kyvik KO, Hjelmborg JB, Skadhauge LR, Steffensen I, Backer V. Importance of genetic factors in the etiology of atopic dermatitis: A twin study. Allergy Asthma Proc. 2007; 28: 535–539. ThomsenSF UlrikCS KyvikKO HjelmborgJB SkadhaugeLR SteffensenI BackerV Importance of genetic factors in the etiology of atopic dermatitis: A twin study Allergy Asthma Proc. 2007 28 535 539 10.2500/aap2007.28.304118034971 Search in Google Scholar

[13] Martin MJ, Estravís M, García-Sánchez A, Dávila I, Isidoro-García M, Sanz C. Genetics and epigenetics of atopic dermatitis: An updated systematic review. Genes. 2020; 11: 442. MartinMJ EstravísM García-SánchezA DávilaI Isidoro-GarcíaM SanzC Genetics and epigenetics of atopic dermatitis: An updated systematic review Genes. 2020 11 442 10.3390/genes11040442723111532325630 Search in Google Scholar

[14] On HR, Lee SE, Kim SE, Hong WJ, Kim HJ, Nomura T, Suzuki S, Shimizu H, Kim SC. Filaggrin mutation in Korean patients with atopic dermatitis. Yonsei Med J. 2017; 58: 395–400. OnHR LeeSE KimSE HongWJ KimHJ NomuraT SuzukiS ShimizuH KimSC Filaggrin mutation in Korean patients with atopic dermatitis Yonsei Med J. 2017 58 395 400 10.3349/ymj.2017.58.2.395529002028120571 Search in Google Scholar

[15] Larsen FS. Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1993; 28: 719–723. LarsenFS Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample J Am Acad Dermatol. 1993 28 719 723 10.1016/0190-9622(93)70099-F8496415 Search in Google Scholar

[16] Tamagawa-Mineoka R, Katoh N. Atopic dermatitis: Identification and management of complicating factors. Int J Mol Sci. 2020; 21: 2671. Tamagawa-MineokaR KatohN Atopic dermatitis: Identification and management of complicating factors Int J Mol Sci. 2020 21 2671 10.3390/ijms21082671721548832290423 Search in Google Scholar

[17] Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum? Curr Opin Immunol. 2017; 48: 68–73. Guttman-YasskyE KruegerJG Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum? Curr Opin Immunol. 2017 48 68 73 10.1016/j.coi.2017.08.00828869867 Search in Google Scholar

[18] Gittler JK, Shemer A, Suárez-Fariñas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, Mitsui H, Cardinale I, de Guzman Strong C, Krueger JG, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012; 130: 1344–1354. GittlerJK ShemerA Suárez-FariñasM Fuentes-DuculanJ GulewiczKJ WangCQ MitsuiH CardinaleI de Guzman StrongC KruegerJG Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis J Allergy Clin Immunol. 2012 130 1344 1354 10.1016/j.jaci.2012.07.012399124522951056 Search in Google Scholar

[19] Silny W, Czarnecka-Operacz M, Gliński W, Samochocki Z, Jenerowicz D. Atopowe zapalenie skóry – współczesne poglądy na patomechanizm oraz metody postępowania diagnostyczno-leczniczego. Stanowisko grupy specjalistów Polskiego Towarzystwa Dermatologicznego. Post Dermatol Alergol. 2010; 27: 365–383. SilnyW Czarnecka-OperaczM GlińskiW SamochockiZ JenerowiczD Atopowe zapalenie skóry – współczesne poglądy na patomechanizm oraz metody postępowania diagnostyczno-leczniczego. Stanowisko grupy specjalistów Polskiego Towarzystwa Dermatologicznego Post Dermatol Alergol. 2010 27 365 383 Search in Google Scholar

[20] Suárez-Fariñas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013; 132: 361–370. Suárez-FariñasM DhingraN GittlerJ ShemerA CardinaleI de Guzman StrongC KruegerJG Guttman-YasskyE Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis J Allergy Clin Immunol. 2013 132 361 370 10.1016/j.jaci.2013.04.046399124023777851 Search in Google Scholar

[21] Czarnowicki T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol. 2017; 139: 1723–1734. CzarnowickiT KruegerJG Guttman-YasskyE Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march J Allergy Clin Immunol. 2017 139 1723 1734 10.1016/j.jaci.2017.04.00428583445 Search in Google Scholar

[22] Han H, Roan F, Ziegler SF. The atopic march: Current insights into skin barrier dysfunction and epithelial cell-derived cytokines. Immunol Rev. 2017; 278: 116–130. HanH RoanF ZieglerSF The atopic march: Current insights into skin barrier dysfunction and epithelial cell-derived cytokines Immunol Rev. 2017 278 116 130 10.1111/imr.12546549295928658558 Search in Google Scholar

[23] Maksimovic N, Zaric M, Bjelica S, Marinkovic JE, Jankovic S. Psychosomatic factors of atopic dermatitis exacerbation. Int J Dermatol. 2018; 57: 1080–1084. MaksimovicN ZaricM BjelicaS MarinkovicJE JankovicS Psychosomatic factors of atopic dermatitis exacerbation Int J Dermatol. 2018 57 1080 1084 10.1111/ijd.1407629869332 Search in Google Scholar

[24] Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol. 1985; 65: 102–105. WernerY LindbergM Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis Acta Derm Venereol. 1985 65 102 105 10.2340/0001555565102105 Search in Google Scholar

[25] Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014; 14: 433. AgrawalR WoodfolkJA Skin barrier defects in atopic dermatitis Curr Allergy Asthma Rep. 2014 14 433 10.1007/s11882-014-0433-9403405924633617 Search in Google Scholar

[26] Jenerowicz D, Polańska A. Patomechanizm, bariera naskórkowa i jej defekt w atopowym zapaleniu skóry. W: Silny W (ed): Atopowe zapalenie skóry. Termedia, Poznań 2012: 29–154. JenerowiczD PolańskaA Patomechanizm, bariera naskórkowa i jej defekt w atopowym zapaleniu skóry W: SilnyW (ed): Atopowe zapalenie skóry Termedia Poznań 2012 29 154 Search in Google Scholar

[27] Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980; 92: 44–47. HanifinJM RajkaG Diagnostic features of atopic dermatitis Acta Derm Venereol. 1980 92 44 47 10.2340/00015555924447 Search in Google Scholar

[28] Fal A. Alergia, choroby alergiczne, astma. Tom II. Medycyna Praktyczna. Kraków 2011: 301–315. FalA Alergia, choroby alergiczne, astma. Tom II. Medycyna Praktyczna Kraków 2011 301 315 Search in Google Scholar

[29] Jutel M. Rozpoznawanie chorób alergicznych w podstawowej opiece zdrowotnej. Podsumowanie zaleceń grupy ekspertów EAACI 2014. Med Prakt. 2014; 7–8: 60–68. JutelM Rozpoznawanie chorób alergicznych w podstawowej opiece zdrowotnej. Podsumowanie zaleceń grupy ekspertów EAACI 2014 Med Prakt. 2014 7–8 60 68 Search in Google Scholar

[30] Stanowiska Paneli Eksperckich Polskiego Towarzystwa Alergologicznego pod redakcją J. Kruszewskiego, M.L. Kowalskiego, M. Kulusa. Standardy w Alergologii. Wydanie III. Termedia Wydawnictwa Medyczne, Poznań, 2019. Stanowiska Paneli Eksperckich Polskiego Towarzystwa Alergologicznego pod redakcją KruszewskiegoJ. KowalskiegoM.L. KulusaM. Standardy w Alergologii. Wydanie III Termedia Wydawnictwa Medyczne Poznań 2019 Search in Google Scholar

[31] Fornal R, Kurzawa R, Błażowski Ł, Sak I. Nieżyt nosa – najważniejsze fenotypy i endotypy oraz zasady leczenia. Alergia Astma Immunologia. 2015; 20: 242–252. FornalR KurzawaR BłażowskiŁ SakI Nieżyt nosa – najważniejsze fenotypy i endotypy oraz zasady leczenia Alergia Astma Immunologia. 2015 20 242 252 Search in Google Scholar

[32] Panaszek B, Szmagierowski W. Źródła alergenów reagujących krzyżowo i ich znaczenie kliniczne. Alergia. 2010; 4: 32–38. PanaszekB SzmagierowskiW Źródła alergenów reagujących krzyżowo i ich znaczenie kliniczne Alergia. 2010 4 32 38 Search in Google Scholar

[33] Dickel H, Kuhlmann L, Bauer A, Bircher AJ, Breuer K., Fuchs T, Grabbe J, Mahler V, Pfofler C, Przybilla B. et al: Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000–2015: A retrospective multicentre study. Dermatol Venereol. 2020; 34: 2086–2095. DickelH KuhlmannL BauerA BircherAJ BreuerK. FuchsT GrabbeJ MahlerV PfoflerC PrzybillaB Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000–2015: A retrospective multicentre study Dermatol Venereol. 2020 34 2086 2095 10.1111/jdv.1625032003071 Search in Google Scholar

[34] Labrosse R, Graham F, Caubet JC. Non-IgE-mediated gastrointestinal food allergies in children: An update. Nutrients. 2020; 12: 2086. LabrosseR GrahamF CaubetJC Non-IgE-mediated gastrointestinal food allergies in children: An update Nutrients. 2020 12 2086 10.3390/nu12072086740085132674427 Search in Google Scholar

[35] Venter C, Brown T, Meyer R, Walsh J, Shah N, Nowak-Węgrzyn A, Chen TX, Fleischer DM, Heine RG, Levin M, et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP – an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017; 7: 1–9. VenterC BrownT MeyerR WalshJ ShahN Nowak-WęgrzynA ChenTX FleischerDM HeineRG LevinM Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP – an international interpretation of the MAP (Milk Allergy in Primary Care) guideline Clin Transl Allergy. 2017 7 1 9 10.1186/s13601-017-0162-y556772328852472 Search in Google Scholar

[36] Karczewska J, Ukleja-Sokołowska N, Bartuzi Z. Alergia pokarmowa a atopowe zapalenie skóry. Aktualne poglądy i opinie. Alergia Astma Immunologia. 2019; 24: 156–163. KarczewskaJ Ukleja-SokołowskaN BartuziZ Alergia pokarmowa a atopowe zapalenie skóry. Aktualne poglądy i opinie Alergia Astma Immunologia. 2019 24 156 163 Search in Google Scholar

[37] Andersen L, Nyeland ME, Nyberg F. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020; 182: 1176–1183. AndersenL NyelandME NybergF Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020 182 1176 1183 10.1111/bjd.18451731818131437300 Search in Google Scholar

[38] Talamonti M, Galluzzo M, Silvaggio D, Lombardo P, Tartaglia C, Bianchi L. Quality of life and psychological impact in patients with atopic dermatitis. J Clin Med. 2021; 10: 1298. TalamontiM GalluzzoM SilvaggioD LombardoP TartagliaC BianchiL Quality of life and psychological impact in patients with atopic dermatitis J Clin Med. 2021 10 1298 10.3390/jcm10061298800390933801061 Search in Google Scholar

[39] Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19: 210–216. FinlayAY KhanGK Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use Clin Exp Dermatol. 1994 19 210 216 10.1111/j.1365-2230.1994.tb01167.x8033378 Search in Google Scholar

[40] Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2003; 9: 169–180. LewisV FinlayAY 10 years experience of the Dermatology Life Quality Index (DLQI) J Investig Dermatol Symp Proc. 2003 9 169 180 10.1111/j.1087-0024.2004.09113.x15083785 Search in Google Scholar

[41] Tyc-Zdrojewska E, Trznadel-Grodzka E, Kaszuba A. Wpływ przewlekłych chorób skóry na jakość życia pacjentów. Dermatol Klin. 2011; 13: 155–160. Tyc-ZdrojewskaE Trznadel-GrodzkaE KaszubaA Wpływ przewlekłych chorób skóry na jakość życia pacjentów Dermatol Klin. 2011 13 155 160 Search in Google Scholar

[42] Baranowska A, Krajewska-Kułak E, Szyszko-Perłowska A, Bielemuk A, Jankowiak B, Rozwadowska E. Problem jakości życia w dermatologii. Probl Pielęg. 2011; 19: 109–115. BaranowskaA Krajewska-KułakE Szyszko-PerłowskaA BielemukA JankowiakB RozwadowskaE Problem jakości życia w dermatologii Probl Pielęg. 2011 19 109 115 Search in Google Scholar

[43] Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC. The burden of atopic dermatitis: Impact on the patient, family, and society. Pediatr Dermatol. 2005; 22: 192–199. CarrollCL BalkrishnanR FeldmanSR FleischerABJr ManuelJC The burden of atopic dermatitis: Impact on the patient, family, and society Pediatr Dermatol. 2005 22 192 199 10.1111/j.1525-1470.2005.22303.x15916563 Search in Google Scholar

[44] Schmitt J, Buske-Kirschbaum A, Tesch F, Trikojat K, Stephan V, Abraham S, Bauer A, Nemat K, Plessow F, Roessner V. Increased attention-deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use. Allergy. 2018; 73: 615–626. SchmittJ Buske-KirschbaumA TeschF TrikojatK StephanV AbrahamS BauerA NematK PlessowF RoessnerV Increased attention-deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use Allergy. 2018 73 615 626 10.1111/all.1332628975640 Search in Google Scholar

[45] Silverberg JI. Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol. 2017; 35: 360–366. SilverbergJI Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders Clin Dermatol. 2017 35 360 366 10.1016/j.clindermatol.2017.03.008551243828709566 Search in Google Scholar

[46] Chamsin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther. 2006; 19: 104–107. ChamsinSL The psychosocial burden of childhood atopic dermatitis Dermatol Ther. 2006 19 104 107 10.1111/j.1529-8019.2006.00060.x16669993 Search in Google Scholar

[47] Chamlin SL, Frieden IJ, Wiliams ML. Effects of atopic dermatitis on young American children and their families. Pediatrics. 2004; 114: 607–611. ChamlinSL FriedenIJ WiliamsML Effects of atopic dermatitis on young American children and their families Pediatrics. 2004 114 607 611 10.1542/peds.2004-037415342828 Search in Google Scholar

[48] Kmieć ML, Broniarczyk-Dyła G. Aspekty psychologiczne związane z atopowym zapaleniem skóry. Derm Klin. 2009; 11: 237–240. KmiećML Broniarczyk-DyłaG Aspekty psychologiczne związane z atopowym zapaleniem skóry Derm Klin. 2009 11 237 240 Search in Google Scholar

[49] Żelazny I. Jakość życia w atopowym zapaleniu skóry. Rozprawa na stopień doktora nauk medycznych. Gdańsk, 2010. ŻelaznyI Jakość życia w atopowym zapaleniu skóry. Rozprawa na stopień doktora nauk medycznych Gdańsk 2010 Search in Google Scholar

[50] Hon KL. Lam MC. Wong KY. Leung TF. Ng PC. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: The role of brain-derived neurotrophic factor and substance P. Br J Dermatol. 2007; 157: 922–925. HonKL LamMC WongKY LeungTF NgPC Pathophysiology of nocturnal scratching in childhood atopic dermatitis: The role of brain-derived neurotrophic factor and substance P Br J Dermatol. 2007 157 922 925 10.1111/j.1365-2133.2007.08149.x17725670 Search in Google Scholar

[51] Heyer GR, Hornstein OP. Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol. 1999; 26: 77–86. HeyerGR HornsteinOP Recent studies of cutaneous nociception in atopic and non-atopic subjects J Dermatol. 1999 26 77 86 10.1111/j.1346-8138.1999.tb03516.x10091477 Search in Google Scholar

[52] Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol. 2008; 22: 223–228. SalomonJ BaranE The role of selected neuropeptides in pathogenesis of atopic dermatitis J Eur Acad Dermatol Venereol. 2008 22 223 228 10.1111/j.1468-3083.2007.02399.x18211417 Search in Google Scholar

[53] Weisshaar E, Gieler U, Kupfer J, Furue M, Saeki H, Yosipovitch G. International Forum on the Study of Itch. Questionnaires to assess chronic itch: A consensus paper of the special interest group of the International Forum on the Study of Itch. Acta Derm Venereol. 2012; 92: 493–496. WeisshaarE GielerU KupferJ FurueM SaekiH YosipovitchG International Forum on the Study of Itch. Questionnaires to assess chronic itch: A consensus paper of the special interest group of the International Forum on the Study of Itch Acta Derm Venereol. 2012 92 493 496 10.2340/00015555-140222688895 Search in Google Scholar

[54] Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, et al.: Clinical classification of itch: A position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007; 87: 291–294. StanderS WeisshaarE MettangT SzepietowskiJC CarstensE IkomaA BergasaNV GielerU MiseryL WallengrenJ Clinical classification of itch: A position paper of the International Forum for the Study of Itch Acta Derm Venereol. 2007 87 291 294 10.2340/00015555-030517598029 Search in Google Scholar

[55] Lee HG, Stull C, Yosipovitch G. Psychiatric disorders and pruritus. Clin Dermatol. 2017; 35: 273–280. LeeHG StullC YosipovitchG Psychiatric disorders and pruritus Clin Dermatol. 2017 35 273 280 10.1016/j.clindermatol.2017.01.00828511824 Search in Google Scholar

[56] Chamlin SL, Mattson CL, Frieden IJ, Williams ML, Mancini AJ, Cella D, Chren MM. The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med. 2005; 159: 745–750. ChamlinSL MattsonCL FriedenIJ WilliamsML ManciniAJ CellaD ChrenMM The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis Arch Pediatr Adolesc Med. 2005 159 745 750 10.1001/archpedi.159.8.74516061782 Search in Google Scholar

[57] Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993; 186: 23–31. Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis Dermatology. 1993 186 23 31 10.1159/0002472988435513 Search in Google Scholar

[58] Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. JEADV. 2018; 32: 657–682. WollenbergA BarbarotS BieberT Christen-ZaechS DeleuranM Fink-WagnerA GielerU GirolomoniG LauS MuraroA Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I JEADV. 2018 32 657 682 Search in Google Scholar

[59] Chrostowska-Plak D, Salomon J, Reich A, Szepietowski J. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol. 2009; 89: 379–383. Chrostowska-PlakD SalomonJ ReichA SzepietowskiJ Clinical aspects of itch in adult atopic dermatitis patients Acta Derm Venereol. 2009 89 379 383 10.2340/00015555-067619688150 Search in Google Scholar

[60] Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002; 41: 212–216. YosipovitchG GoonAT WeeJ ChanYH ZuckerI GohCL Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus Int J Dermatol. 2002 41 212 216 10.1046/j.1365-4362.2002.01460.x12031029 Search in Google Scholar

[61] Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, La Vecchia C. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: A meta-analysis. Epidemiology. 2012; 23: 402–414. PelucchiC ChatenoudL TuratiF GaleoneC MojaL BachJF La VecchiaC Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: A meta-analysis Epidemiology. 2012 23 402 414 10.1097/EDE.0b013e31824d5da222441545 Search in Google Scholar

[62] Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, Murrell DF, Tang ML, Roberts A, Boyle RJ.: Probiotics for treating eczema. Cochrane Database Syst Rev. 2018; 11: CD006135. MakrgeorgouA Leonardi-BeeJ Bath-HextallFJ MurrellDF TangML RobertsA BoyleRJ Probiotics for treating eczema Cochrane Database Syst Rev. 2018 11 CD006135 10.1002/14651858.CD006135.pub3651724230480774 Search in Google Scholar

[63] D’Elios S, Trambusti I, Verduci E, Ferrante G, Rosati S, Marseglia GL, Drago L, Peroni DG Probiotics in the prevention and treatment of atopic dermatitis. Pediatr Allergy Immunol. 2020; 31: 43–45. D’EliosS TrambustiI VerduciE FerranteG RosatiS MarsegliaGL DragoL PeroniDG Probiotics in the prevention and treatment of atopic dermatitis Pediatr Allergy Immunol. 2020 31 43 45 10.1111/pai.1336433236423 Search in Google Scholar

[64] Boulos S, Yan AC. Current concepts in the prevention of atopic dermatitis. Clin Dermatol. 2018; 36: 668–671. BoulosS YanAC Current concepts in the prevention of atopic dermatitis Clin Dermatol. 2018 36 668 671 10.1016/j.clindermatol.2017.03.00430217281 Search in Google Scholar

[65] Hon KL, Kung JSC, Ng WGG, Leung TF. Emollient treatment of atopic dermatitis: latest evidence and clinical considerations. Drugs Context. 2018; 7: 212530. HonKL KungJSC NgWGG LeungTF Emollient treatment of atopic dermatitis: latest evidence and clinical considerations Drugs Context. 2018 7 212530 10.7573/dic.212530590826729692852 Search in Google Scholar

[66] Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, et al.: Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol. 2012; 26: 1045–1060. RingJ AlomarA BieberT DeleuranM Fink-WagnerA GelmettiC GielerU LipozencicJ LugerT OranjeAP Guidelines for treatment of atopic eczema (atopic dermatitis) Part I J Eur Acad Dermatol Venereol. 2012 26 1045 1060 10.1111/j.1468-3083.2012.04635.x22805051 Search in Google Scholar

[67] Buczyłko K. Znaczenie redukcji narażenia na alergeny sezonowe w leczeniu alergii. Alergia Astma Immunologia. 2011; 16: 17–23. BuczyłkoK Znaczenie redukcji narażenia na alergeny sezonowe w leczeniu alergii Alergia Astma Immunologia. 2011 16 17 23 Search in Google Scholar

[68] Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part II. J Eur Acad Dermatol Venereol. 2018; 32: 850–878. WollenbergA BarbarotS BieberT Christen-ZaechS DeleuranM Fink-WagnerA GielerU GirolomoniG LauS Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part II J Eur Acad Dermatol Venereol. 2018 32 850 878 10.1111/jdv.1488829878606 Search in Google Scholar

[69] Oranje AP, Devillers AC, Kunz B, Jones SL, DeRaeve L, Van Gysel D, de Waard-van der Spek FB, Grimalt R, Torrelo A, Stevens J, Harper J. Treatment of patients with atopic dermatitis. Using wet-wrap-dressings with diluted steroids and/or emollients. An export-panel’s opinion and review of the literature. J Eur Acad Dermatol Venereol. 2006; 20: 1277–1286. OranjeAP DevillersAC KunzB JonesSL DeRaeveL Van GyselD de Waard-van der SpekFB GrimaltR TorreloA StevensJ HarperJ Treatment of patients with atopic dermatitis. Using wet-wrap-dressings with diluted steroids and/or emollients. An export-panel’s opinion and review of the literature J Eur Acad Dermatol Venereol. 2006 20 1277 1286 10.1111/j.1468-3083.2006.01790.x17062046 Search in Google Scholar

[70] Janmohamed SR, Oranje AP, Devillers AC, Rizopoulos D, van Praag MC, Van Gysel D, Goeteyn M, de Waard-van der Spek FB. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2014; 70: 1076–1082. JanmohamedSR OranjeAP DevillersAC RizopoulosD van PraagMC Van GyselD GoeteynM de Waard-van der SpekFB The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled trial J Am Acad Dermatol. 2014 70 1076 1082 10.1016/j.jaad.2014.01.89824698702 Search in Google Scholar

[71] Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: Clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol. 2005; 152: 130–141. GreenC ColquittJL KirbyJ DavidsonP Topical corticosteroids for atopic eczema: Clinical and cost effectiveness of once-daily vs. more frequent use Br J Dermatol. 2005 152 130 141 10.1111/j.1365-2133.2005.06410.x15656813 Search in Google Scholar

[72] Kaszuba A, Pastuszka M, Kaszuba A. Miejscowe glikokortykosteroidy w leczeniu chorób skóry - zalecane standardy postępowania. Forum Medycyny Rodzinnej. 2009; 3: 347–358. KaszubaA PastuszkaM KaszubaA Miejscowe glikokortykosteroidy w leczeniu chorób skóry - zalecane standardy postępowania Forum Medycyny Rodzinnej. 2009 3 347 358 Search in Google Scholar

[73] Paller AS, Lebwohl M, Fleischer AB Jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005; 52: 810–822. PallerAS LebwohlM FleischerAB AntayaRJr LangleyRG KirsnerRS BlumRR RicoMJ JaraczE CroweA LinowskiGJ US/Canada Tacrolimus Ointment Study Group Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies J Am Acad Dermatol. 2005 52 810 822 10.1016/j.jaad.2004.12.03815858471 Search in Google Scholar

[74] Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001; 44 (1 Suppl): S58–S64. KangS LuckyAW PariserD LawrenceI HanifinJM Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children J Am Acad Dermatol. 2001 44 1 Suppl S58 S64 10.1067/mjd.2001.10981211145796 Search in Google Scholar

[75] Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011; 164: 415–428. SchmittJ von KobyletzkiL SvenssonA ApfelbacherC Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials Br J Dermatol. 2011 164 415 428 10.1111/j.1365-2133.2010.10030.x20819086 Search in Google Scholar

[77] Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, et al.: Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016; 75: 494–503. PallerAS TomWL LebwohlMG BlumenthalRL BoguniewiczM CallRS EichenfieldLF ForshaDW ReesWC SimpsonEL Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults J Am Acad Dermatol. 2016 75 494 503 10.1016/j.jaad.2016.05.04627417017 Search in Google Scholar

[78] Dotterud LK, Wilsgaard T, Vorland LH, Falk ES. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int J Circumpolar Health. 2008; 67: 254–260. DotterudLK WilsgaardT VorlandLH FalkES The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls Int J Circumpolar Health. 2008 67 254 260 10.3402/ijch.v67i2-3.1828218767345 Search in Google Scholar

[79] Rodenbeck DL, Silverberg JI, Silverberg NB. Phototherapy for atopic dermatitis. Clin Dermatol. 2016; 34: 607–613. RodenbeckDL SilverbergJI SilverbergNB Phototherapy for atopic dermatitis Clin Dermatol. 2016 34 607 613 10.1016/j.clindermatol.2016.05.01127638440 Search in Google Scholar

[80] Kobusiewicz A, Zalewska-Janowska AM, Lesiak A, Narbutt J. Management of severe atopic dermatitis in adult patients. Przegl Dermatol. 2020; 107: 234–245. KobusiewiczA Zalewska-JanowskaAM LesiakA NarbuttJ Management of severe atopic dermatitis in adult patients Przegl Dermatol. 2020 107 234 245 10.5114/dr.2020.97785 Search in Google Scholar

[81] Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, et al.: When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol. 2017; 77: 623–633. SimpsonEL Bruin-WellerM FlohrC Ardern-JonesMR BarbarotS DeleuranM BieberT VestergaardC BrownSJ CorkMJ When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council J Am Acad Dermatol. 2017 77 623 633 10.1016/j.jaad.2017.06.04228803668 Search in Google Scholar

[82] Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010; 65: 805–821. BuddenkotteJ SteinhoffM Pathophysiology and therapy of pruritus in allergic and atopic diseases Allergy. 2010 65 805 821 10.1111/j.1398-9995.2010.01995.x20384615 Search in Google Scholar

[83] Andrade A, Kuah CY, Martin-Lopez JE, Chua S, Shpadaruk V, Sanclemente G, Franco JV. Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev. 2020; 25: CD013128. AndradeA KuahCY Martin-LopezJE ChuaS ShpadarukV SanclementeG FrancoJV Interventions for chronic pruritus of unknown origin Cochrane Database Syst Rev. 2020 25 CD013128 10.1002/14651858.CD013128.pub2698465031981369 Search in Google Scholar

[84] Deleanu D, Nedelea I. Biological therapies for atopic dermatitis: An update. Exp Ther Med. 2019; 17: 1061–1067. DeleanuD NedeleaI Biological therapies for atopic dermatitis: An update Exp Ther Med. 2019 17 1061 1067 10.3892/etm.2018.6989632767230679974 Search in Google Scholar

[85] Brunner PM, Guttman-Yassky E, Leung DYM. The immunology of AD and its reversibility with broad spectrum and targeted therapies. J Allergy Clin Immunol. 2017; 139 (suppl 4): S65–S76. BrunnerPM Guttman-YasskyE LeungDYM The immunology of AD and its reversibility with broad spectrum and targeted therapies J Allergy Clin Immunol. 2017 139 suppl 4 S65 S76 10.1016/j.jaci.2017.01.011540570228390479 Search in Google Scholar

[86] Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, et al.: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018; 32: 850–878. WollenbergA BarbarotS BieberT Christen-ZaechS DeleuranM Fink-WagnerA GielerU GirolomoniG LauS MuraroA Czarnecka-OperaczM Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II J Eur Acad Dermatol Venereol. 2018 32 850 878 10.1111/jdv.1488829878606 Search in Google Scholar

[87] Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018; 11: 467–474. SeegräberM SrourJ WalterA KnopM WollenbergA Dupilumab for treatment of atopic dermatitis Expert Rev Clin Pharmacol. 2018 11 467 474 10.1080/17512433.2018.144964229557246 Search in Google Scholar

[88] Wang FP, Tang XJ, Wei CQ, Xu LR, Mao H, Luo FM. Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis. J Dermatol Sci. 2018; 90: 190–198. WangFP TangXJ WeiCQ XuLR MaoH LuoFM Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis J Dermatol Sci. 2018 90 190 198 10.1016/j.jdermsci.2018.01.01629472119 Search in Google Scholar

[89] Treister AD, Lio P. Long-term off-label dupilumab in pediatric atopic dermatitis: A case series. Pediatr Dermatol. 2019; 36: 85–88. TreisterAD LioP Long-term off-label dupilumab in pediatric atopic dermatitis: A case series Pediatr Dermatol. 2019 36 85 88 10.1111/pde.1369730338546 Search in Google Scholar

[90] Snast I, Reiter O, Hodak E, Friedland R, Mimouni D, Leshem YA. Are biologics efficacious in atopic dermatitis? A systematic review and metaanalysis. Am J Clin Dermatol. 2018; 19: 145–165. SnastI ReiterO HodakE FriedlandR MimouniD LeshemYA Are biologics efficacious in atopic dermatitis? A systematic review and metaanalysis Am J Clin Dermatol. 2018 19 145 165 10.1007/s40257-017-0324-729098604 Search in Google Scholar

[91] Klonowska J, Gleń J, Nowicki RJ, Trzeciak M. New cytokines in the pathogenesis of atopic dermatitis-new therapeutic targets. Int J Mol Sci. 2018; 19: 3086. KlonowskaJ GleńJ NowickiRJ TrzeciakM New cytokines in the pathogenesis of atopic dermatitis-new therapeutic targets Int J Mol Sci. 2018 19 3086 10.3390/ijms19103086621345830304837 Search in Google Scholar

[92] Łacwik P, Kupczyk M, Kuna P: Immunoterapia alergenowa - nowe stanowisko Polskiego Towarzystwa Alergologicznego 2019. Terapia. Alergologia. 2019; 4: 95–99. ŁacwikP KupczykM KunaP Immunoterapia alergenowa - nowe stanowisko Polskiego Towarzystwa Alergologicznego 2019 Terapia. Alergologia. 2019 4 95 99 Search in Google Scholar

[93] Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015; 8: 17. AkdisCA AkdisM Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens World Allergy Organ J. 2015 8 17 10.1186/s40413-015-0063-2443087426023323 Search in Google Scholar

[94] Smith DM, Freeman TM. Sublingual immunotherapy for other indications. Venom large local, latex, atopic dermatitis, and food. Immunol Allergy Clin N Am. 2020; 40: 41–57. SmithDM FreemanTM Sublingual immunotherapy for other indications. Venom large local, latex, atopic dermatitis, and food Immunol Allergy Clin N Am. 2020 40 41 57 10.1016/j.iac.2019.09.01131761120 Search in Google Scholar

[95] Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, Nowak-Wegrzyn A, Peters A, Collins C, Bernstein DI, et al. Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol. 2017; 118: 276–282. GreenhawtM OppenheimerJ NelsonM NelsonH LockeyR LiebermanP Nowak-WegrzynA PetersA CollinsC BernsteinDI Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update Ann Allergy Asthma Immunol. 2017 118 276 282 10.1016/j.anai.2016.12.00928284533 Search in Google Scholar

[96] Jutel M, Bartkowiak-Emeryk M, Bręborowicz A, Cichocka-Jarosz E, Emeryk A, Gawlik R, Gonerko P, Rogala B, Nowak-Węgrzyn A, Samoliński B. Sublingual immunotherapy (SLIT)- indications, mechanism, and efficacy. Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy. Ann Agric Environ Med. 2016; 23: 44–53. JutelM Bartkowiak-EmerykM BręborowiczA Cichocka-JaroszE EmerykA GawlikR GonerkoP RogalaB Nowak-WęgrzynA SamolińskiB Sublingual immunotherapy (SLIT)- indications, mechanism, and efficacy. Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy Ann Agric Environ Med. 2016 23 44 53 10.5604/12321966.119685127012173 Search in Google Scholar

[97] Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013; 132: 110–117. BaeJM ChoiYY ParkCO ChungKY LeeKH Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials J Allergy Clin Immunol. 2013 132 110 117 10.1016/j.jaci.2013.02.04423647790 Search in Google Scholar

[98] Tam HH, Calderon MA, Manikam L, Nankervis H, Núñez IG, Williams HC, Durham SR, Boyle RJ. Specific allergen immunotherapy for the treatment of atopic eczema: A Cochrane systematic review. Allergy. 2016; 71: 1345–1356. TamHH CalderonMA ManikamL NankervisH NúñezIG WilliamsHC DurhamSR BoyleRJ Specific allergen immunotherapy for the treatment of atopic eczema: A Cochrane systematic review Allergy. 2016 71 1345 1356 10.1111/all.1293227184158 Search in Google Scholar

[99] Caminiti L, Panasiti I, Landi M, De Filippo M, Olcese R, Ciprandi G, Vernich M, Carelli F, Votto M, Barberi S. Allergen immunotherapy in atopic dermatitis: Light and shadow in children. Pediatr Allergy Immunol. 2020; 31, Suppl 26: 46–48. CaminitiL PanasitiI LandiM De FilippoM OlceseR CiprandiG VernichM CarelliF VottoM BarberiS Allergen immunotherapy in atopic dermatitis: Light and shadow in children Pediatr Allergy Immunol. 2020 31 Suppl 26 46 48 10.1111/pai.1339033236444 Search in Google Scholar

[100] Eichenfield LF, Ahluwalia J, Waldman A, Borok J, Udkoff J, Boguniewicz M. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017; 139: S49–S57. EichenfieldLF AhluwaliaJ WaldmanA BorokJ UdkoffJ BoguniewiczM Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines J Allergy Clin Immunol. 2017 139 S49 S57 10.1016/j.jaci.2017.01.00928390477 Search in Google Scholar

[101] Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 2018; 32: 657–682. WollenbergA BarbarotS BieberT Christen-ZaechS DeleuranM Fink-WagnerA GielerU GirolomoniG LauS MuraroA Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I J Eur Acad Dermatol Venereol. 2018 32 657 682 10.1111/jdv.1489129676534 Search in Google Scholar

[102] Rizk P, Rodenas M, De Benedetto A. Allergen immunotherapy and atopic dermatitis: The good, the bad, and the unknown. Curr Allergy Asthma Rep. 2019; 19: 57. RizkP RodenasM De BenedettoA Allergen immunotherapy and atopic dermatitis: The good, the bad, and the unknown Curr Allergy Asthma Rep. 2019 19 57 10.1007/s11882-019-0893-z31776678 Search in Google Scholar

[103] Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU, Bindslev-Jensen C, Burks W, Poulsen LK, Sampson HA, et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis - PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016; 137: 1347–1358. MuraroA LemanskeRFJr CastellsM TorresMJ KhanD SimonHU Bindslev-JensenC BurksW PoulsenLK SampsonHA Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis - PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology J Allergy Clin Immunol. 2016 137 1347 1358 10.1016/j.jaci.2016.03.01027155030 Search in Google Scholar